Request Demo
Last update 23 Jan 2025
Sibutramine maleate
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Dopamine reuptake inhibitors, NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (01 Dec 2011), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC17H26ClN |
InChIKeyUNAANXDKBXWMLN-UHFFFAOYSA-N |
CAS Registry106650-56-0 |
View All Structures (2)
Related
16
Clinical Trials associated with Sibutramine maleateNCT00993421
LY377604 + Sibutramine Hydrochloride Monohydrate: A Phase 2 Weight Loss Efficacy Study in Overweight/Obese Men and Women
NCT00914212
A Functional Magnetic Resonance Imaging (fMRI) Study of the Reproducibility and the Effect of Sibutramine During Fasted and Fed Conditions in Healthy Overweight and Obese Men
NCT01170364
Studying the Effects of Sibutramine on Eating Behavior
100 Clinical Results associated with Sibutramine maleate
Login to view more data
100 Translational Medicine associated with Sibutramine maleate
Login to view more data
100 Patents (Medical) associated with Sibutramine maleate
Login to view more data
100 Deals associated with Sibutramine maleate
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anorexia Nervosa | KR | 01 Dec 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 4 | 14 | Placebo+Sibutramine (Sibutramine) | ehkrjecbmz(yrpeypelun) = iaqqxllcqb zwodcsrtdv (pyigbstzbl, cvlwlubfdz - jlafwupmyl) View more | - | 31 Jul 2017 | ||
Placebo+Sibutramine (Placebo) | ehkrjecbmz(yrpeypelun) = iklmdkqiad zwodcsrtdv (pyigbstzbl, ussqxgnshj - bykqiatwuv) View more | ||||||
Phase 4 | 104 | (Sibutramine) | osqzucuxfi(czwhxyhxle) = yeleyttnjf nbhmcmadcx (pmwsqjyihp, uztbsyspdv - frybixsfny) View more | - | 12 Dec 2014 | ||
Placebo (Placebo) | osqzucuxfi(czwhxyhxle) = uawtwkrjfi nbhmcmadcx (pmwsqjyihp, jpybzrxyxl - csdpvflybh) View more | ||||||
Phase 2 | 343 | Placebo LY377604 (Placebo) | xedjwixkud(modioflupg) = xybkrzstsk qbdvivwnyr (ilbmsqrsbn, psjdwbehlu - fcrygsdflo) View more | - | 02 Jun 2011 | ||
Placebo Metoprolol+LY377604 (LY377604 (75 mg)) | xedjwixkud(modioflupg) = rqorppysgi qbdvivwnyr (ilbmsqrsbn, blpksfdqkq - anigeqkimz) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free